Hong Kong-listed Innovative Medicine ETF rose more than 3%

Hong Kong stocks innovative pharmaceutical ETF rose more than 3%, with a premium rate of 0.52%, trading volume of 68.91 billion yuan, higher than the same time yesterday by 61.76%, an increase of 4.61 billion shares in the past month, and the fund supports T+0 trading.